Skip to main content

Information about available vaccines



From the beginning of the pandemic, the greatest effort of all scientists from around the world is to develop a safe vaccine against new coronavirus. To ensure maximal safety, only EU-approved vaccines are allowed for usage in the Czech Republic (more about the vaccine approval process can be found in Related Links).

A vaccine against Covid-19 is a drug protecting given individual from the disease caused by the new coronavirus SARS-CoV-2 by inducing immune system reaction against the virus. In layman’s terms, the vaccine learns the body where are the weaknesses of the virus and how to produce adequate immune system reaction so that your immune system could kill the virus before its reproduction in the body.

Four of the existing vaccines are registered in the EU so far. 

Overview of existing vaccines

Vaccines approved by EMA for the usage within the EU member states:

COMIRNATY
Manufacturer: Pfizer/BioNTech

Vaccine type: mRNA, coated with lipid nanoparticles.

Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from the 2nd dose.

Registered in EU: 21.12.2020

number of doses per person: 2

The interval between the doses according to SPC: 21 days 

Approved age limit for usage: +5

Vaccination cannot induce Covid-19 disease as the vaccine does not include a live virus.

More can be found in the State Institute for Drug Control press report.

4.10. The EMA approved (only in Czech) an additional dose of Comirnaty for people with weakened immunity at least 28 days after the second dose and a booster dose of Comirnaty for people aged 18-55 years at least 6 months after the second dose.

25.11. EMA recommended the Comirnaty vaccine (only in Czech) for vaccination of children aged 5-11 years. 26.11. The European Commission approved the recommendation. Children will be vaccinated with a reduced dose.

Based on the decision of the Ministry of Health (only in Czech), the booster dose will be administered to persons over 18 years of age 5 months after completion of the basic vaccination schedule from 4th January.

SPIKEVAX
Manufacturer: Moderna

Vaccine type: mRNA, coated with lipid nanoparticles

Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from the 2nd dose.

Registered in EU: 6.1.2021

Number of doses per person: 2

The interval between the doses according to SPC28 days 

Approved age limit for usage: 12+

Vaccination cannot induce Covid-19 disease as the vaccine does not include live viruses.

More can be found in the State Institute for Drug Control press report.

4.10. The EMA approved an additional dose of Spikevax for people with weakened immunity at least 28 days after the second dose.

Based on the decision of the Ministry of Health (only in Czech), the booster dose will be administered to persons over 18 years of age 5 months after completion of the basic vaccination schedule from 4th January.

VAXZEVRIA
Manufacturer: AstraZeneca

Vaccine type: vector-based (adenovirus ChAdOx1)

Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from the 2nd dose.

Registered in EU: 29.1.2021

Number of doses per person: 2

The interval between the doses according to SPC: 28 - 84 days

Approved age limit for usage: +18 (Recommended for individuals +60 based on Ministry of Health press report)

Vaccination cannot induce Covid-19 disease as the vaccine does not include live viruses. Adenovirus modification precludes any possibility of inducing the Covid-19 disease.

More can be found in the State Institute for Drug Control press report.

JANSSEN
Manufacturer: Janssen Pharmaceutica (Johnson & Johnson)
Vaccine type: vector-based (adenovirus Ad26)

Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from vaccination

Registered in EU: 11.3.2021

Number of doses per person: 1

Approved age limit for usage: +18 (Recommended for individuals +60 based on Ministry of Health press report)

Vaccination cannot induce Covid-19 disease as the vaccine does not include live viruses. Adenovirus modification precludes any possibility of inducing the Covid-19 disease.

NUVAXOVID (former NVX-COV2373)

Manufacturer: Novavax

Vaccine type: protein-based, adjuvanted

Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid for 14 days after vaccination.

Registered in EU: 20.12.2021

Number of doses per person: 2

The time between doses according to SPC: 21 days

Approved age limit for usage: +18

More can be found in the State Institute for Drug Control press report. 

At ockoreport.uzis.cz you can find information on how to reschedule an inconvenient vaccination date for each vaccination site.

The main difference between conditional and standard vaccine registration is the duration for which the registration is granted. For conditional registration it is one year, for standard registration it is five years. After the expiry of the period, it is possible to apply for renewal of the registration by submitting additional data. Regardless of the type of registration, vaccines are monitored as part of post-registration monitoring. A vaccine can only be registered if its benefits outweigh the risks.

Vaccines under EMA assessment procedure for the use in the EU:

SPUTNIK V (Gam-COVID-Vac)

Manufacturer: Nikolai Gamalei Institute of Epidemiological and Microbiological Research, Moscow

Vaccine type: vector-based (adenovirus rAd26 a rAd5)

Recognized for the EU COVID digital certificate: no

Assessment procedure start: 4.3.2021

Number of doses per person: 2

State Institute for Drug Control press report regarding assessment procedure start.

VERO CELL (CoronaVac)

Manufacturer: Sinovac

Vaccine type: inactivated viral, adjuvanted

Recognized for the EU COVID digital certificate: no

Assessment procedure start: 4.5.2021

Number of doses per person: 2

State Institute for Drug Control press report regarding assessment procedure start.

VIDPREVTYN

Manufacturer: Sanofi Pasteur/GlaxoSmithKline

Vaccine type: protein-based, adjuvanted

Recognized for the EU COVID digital certificate: no

Assessment procedure start: 20.7.2021

Number of doses per person: 2

State Institute for Drug Control press report regarding assessment procedure start.

VLA2001

Manufacturer: Valneva 

Vaccine type: inactivated viral, adjuvanted

Recognized for the EU COVID digital certificate: no

Assessment procedure start: 20.7.2021

Number of doses per person: 2

State Institute for Drug Control press report regarding assessment procedure start.

Vaccines where the EMA approval process has been stopped

CVNCOV

Manufacturer: CureVac

Vaccine type: mRNA, coated with lipid nanoparticles

Recognized for the EU COVID digital certificate: no

Assessment procedure start: 12.2.2021

Number of doses per person: 2

State Institute for Drug Control press report regarding assessment procedure start.

The approval was stopped following a request from CureVac (only in Czech)

Patent-compliant vaccines approved by the EMA and also approved by the WHO for emergency use

COVISHIELD

This is an Indian production of AstraZeneca vaccine.

Recognized for the EU COVID digital certificate: yes, in the Czech Republic the certificate will be valid after 14 days from the 2nd dose.

The overview and status of the Covid-19 vaccines are regularly released by WHO.

Frequent questions about this topic

How has a Covid vaccine been developed so quickly?